Top Markets
Coin of the day
Joinn Laboratories(China)Co.,Ltd. Joinn Laboratories(China)Co.,Ltd.

Joinn Laboratories(China)Co.,Ltd.

603127
Rang in Aktien #3561
Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of... Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.
Aktienkurs
$6.80
Marktkapitalisierung
$5.09B
Veränderung (1 Tag)
-2.90%
Veränderung (1 Jahr)
52.22%
Land
CN
Handel Joinn Laboratories(China)Co.,Ltd. (603127)

Kategorie

Aktien-Split-Historie für Joinn Laboratories(China)Co.,Ltd. (603127)
Die Aktie Joinn Laboratories(China)Co.,Ltd. (Symbol: 603127) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 26, 2026 statt.
Eine 603127-Aktie, die vor dem Aug 26, 2026 gekauft wurde, entspricht heute 0 603127-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
8 x34
US
7 x47
US
0 -
CN
0 -
US
1 x1
US